Company Filing History:
4 out of 340 
3 out of 937 
3 out of 4 Years Active: 1997-2011
Title: Innovations and Contributions of Stephen Maxwell Taylor
Introduction
Stephen Maxwell Taylor is a notable inventor based in Bellbird Park, Australia. He has made significant contributions to the field of medical research, particularly in the treatment of fibrotic conditions. With a total of 8 patents to his name, Taylor's work has the potential to impact various therapeutic areas.
Latest Patents
One of his latest patents focuses on the use of a C5a receptor antagonist in the treatment of fibrosis. This invention relates to the use of an antagonist of a G protein-coupled receptor in the prevention and/or treatment of fibrosis, including conditions associated with myocardial infarction, diabetes, or certain pulmonary issues. The preferred embodiment of this invention involves a cyclic peptide antagonist of the C5a receptor. Additionally, he has developed cyclic agonists and antagonists of C5A receptors and G protein-coupled receptors, which are useful in treating conditions mediated by these receptors, particularly inflammatory conditions.
Career Highlights
Throughout his career, Stephen Maxwell Taylor has worked with prestigious institutions, including The University of Queensland and the University of Nebraska. His research has contributed to advancements in medical treatments and has garnered attention in the scientific community.
Collaborations
Taylor has collaborated with notable colleagues such as David P Fairlie and Sam D Sanderson. These partnerships have further enriched his research and innovation efforts.
Conclusion
Stephen Maxwell Taylor's contributions to the field of medical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of fibrotic and inflammatory conditions.